DrugCite
Search

CARBOPLATIN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Carboplatin Adverse Events Reported to the FDA Over Time

How are Carboplatin adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Carboplatin, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Carboplatin is flagged as the suspect drug causing the adverse event.

Most Common Carboplatin Adverse Events Reported to the FDA

What are the most common Carboplatin adverse events reported to the FDA?

Dehydration
1510 (2.24%)
Nausea
1403 (2.08%)
Vomiting
1331 (1.97%)
Neutropenia
1292 (1.91%)
Dyspnoea
1205 (1.78%)
Diarrhoea
1116 (1.65%)
Anaemia
1115 (1.65%)
Febrile Neutropenia
1040 (1.54%)
Thrombocytopenia
978 (1.45%)
Pyrexia
968 (1.43%)
Pneumonia
796 (1.18%)
Show More Show More
Fatigue
729 (1.08%)
Hypotension
721 (1.07%)
Asthenia
701 (1.04%)
Haemoglobin Decreased
672 (.99%)
White Blood Cell Count Decreased
617 (.91%)
Sepsis
589 (.87%)
Abdominal Pain
568 (.84%)
Platelet Count Decreased
537 (.79%)
Neutrophil Count Decreased
518 (.77%)
Pancytopenia
483 (.72%)
Pulmonary Embolism
454 (.67%)
Renal Failure Acute
448 (.66%)
Respiratory Failure
410 (.61%)
Mucosal Inflammation
404 (.6%)
Hypokalaemia
402 (.6%)
Pleural Effusion
395 (.58%)
Leukopenia
393 (.58%)
Confusional State
389 (.58%)
Death
380 (.56%)
Chest Pain
369 (.55%)
Dizziness
357 (.53%)
Constipation
348 (.52%)
Malignant Neoplasm Progression
342 (.51%)
Hyponatraemia
341 (.5%)
Dysphagia
338 (.5%)
Deep Vein Thrombosis
336 (.5%)
Syncope
328 (.49%)
Decreased Appetite
300 (.44%)
Tachycardia
298 (.44%)
Rash
294 (.44%)
Atrial Fibrillation
292 (.43%)
Renal Failure
284 (.42%)
Infection
277 (.41%)
Pain
275 (.41%)
Disease Progression
271 (.4%)
General Physical Health Deteriorati...
271 (.4%)
Erythema
269 (.4%)
Urinary Tract Infection
268 (.4%)
Chills
261 (.39%)
Weight Decreased
255 (.38%)
Hypersensitivity
250 (.37%)
Oesophagitis
248 (.37%)
Haematocrit Decreased
247 (.37%)
Cough
244 (.36%)
Blood Creatinine Increased
227 (.34%)
Hypertension
216 (.32%)
Hypomagnesaemia
204 (.3%)
Hypoxia
202 (.3%)
Pneumonitis
197 (.29%)
Malaise
196 (.29%)
Blood Sodium Decreased
191 (.28%)
Neutropenic Sepsis
190 (.28%)
Epistaxis
188 (.28%)
Cardio-respiratory Arrest
186 (.28%)
Interstitial Lung Disease
186 (.28%)
Cardiac Arrest
185 (.27%)
Gastrointestinal Haemorrhage
182 (.27%)
Septic Shock
182 (.27%)
Haemoptysis
181 (.27%)
Flushing
180 (.27%)
Pruritus
178 (.26%)
Infusion Related Reaction
173 (.26%)
Aspartate Aminotransferase Increase...
172 (.25%)
Headache
172 (.25%)
Mental Status Changes
170 (.25%)
Small Intestinal Obstruction
169 (.25%)
Drug Toxicity
167 (.25%)
Convulsion
166 (.25%)
Alanine Aminotransferase Increased
162 (.24%)
Fall
157 (.23%)
Loss Of Consciousness
149 (.22%)
Anorexia
148 (.22%)
Neuropathy Peripheral
148 (.22%)
Oedema Peripheral
148 (.22%)
Myocardial Infarction
146 (.22%)
Chest Discomfort
141 (.21%)
Hyperhidrosis
140 (.21%)
Arthralgia
139 (.21%)
Anxiety
138 (.2%)
Blood Glucose Increased
136 (.2%)
Ileus
136 (.2%)
Back Pain
134 (.2%)
Ascites
133 (.2%)
Heart Rate Increased
133 (.2%)
Hypocalcaemia
132 (.2%)
Stomatitis
130 (.19%)
Sinus Tachycardia
129 (.19%)
Paraesthesia
128 (.19%)
Acute Myeloid Leukaemia
127 (.19%)
Blood Potassium Decreased
126 (.19%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Carboplatin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Carboplatin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Carboplatin

What are the most common Carboplatin adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Carboplatin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Carboplatin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Carboplatin According to Those Reporting Adverse Events

Why are people taking Carboplatin, according to those reporting adverse events to the FDA?

Non-small Cell Lung Cancer
4838
Ovarian Cancer
1471
Breast Cancer
1252
Lung Neoplasm Malignant
673
Small Cell Lung Cancer Stage Unspec...
386
Ovarian Epithelial Cancer
335
Show More Show More
Breast Cancer Metastatic
312
Lung Adenocarcinoma
281
Head And Neck Cancer
262
Chemotherapy
244
Drug Use For Unknown Indication
235
Neoplasm Malignant
234
Endometrial Cancer
156
Lung Cancer Metastatic
155
Non-small Cell Lung Cancer Stage Iv
151
Oesophageal Carcinoma
148
Diffuse Large B-cell Lymphoma
134
Product Used For Unknown Indication
128
Squamous Cell Carcinoma
110
Metastatic Malignant Melanoma
110
Ovarian Cancer Recurrent
109
Bladder Cancer
104
Non-small Cell Lung Cancer Metastat...
103
Neoplasm
89
Neuroblastoma
86
Retinoblastoma
84
Mesothelioma
82
Transitional Cell Carcinoma
81
Adenocarcinoma
81
Medulloblastoma
78
Lung Adenocarcinoma Metastatic
78
Non-hodgkins Lymphoma
70
Germ Cell Cancer
67
Cervix Carcinoma
66
Tonsil Cancer
65
Rhabdomyosarcoma
63
Uterine Cancer
63
Lung Squamous Cell Carcinoma Stage ...
58
Bronchial Carcinoma
58
Metastatic Neoplasm
51
Ovarian Cancer Metastatic
51
Lung Adenocarcinoma Stage Iv
51
Prostate Cancer
49
Glioblastoma Multiforme
48
Lymphoma
47
Malignant Melanoma
47
Malignant Peritoneal Neoplasm
45
Pleural Mesothelioma Malignant
44
Tongue Neoplasm Malignant Stage Uns...
44
Stem Cell Transplant
42
Glioma
42

Drug Labels

LabelLabelerEffective
CarboplatinBedford Laboratories22-OCT-09
CarboplatinBedford Laboratories22-OCT-09
CarboplatinHospira Worldwide, Inc.24-DEC-09
CarboplatinAPP Pharmaceuticals, LLC08-DEC-10
CarboplatinSandoz Inc15-DEC-11
CarboplatinTeva Parenteral Medicines, Inc.14-AUG-12
CarboplatinTeva Parenteral Medicines, Inc.14-AUG-12

Carboplatin Case Reports

What Carboplatin safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Carboplatin. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Carboplatin.